RE: £2.00 by Xmas17 Feb 2026 16:51
Volatility aside (day trades), I still think the market is struggling to price the direction of the core assets.
HPMS / Tyseley – Opening the plant was a milestone, but what the market now needs are steady production. Throughput, yield, revenue per tonne. That’s what underpins confidence in replication, lifts NPV assumptions and ultimately supports EBITDA projections.
Songwe Hill – F-4 submitted, US alignment strengthening. Yes, timelines have slipped versus early expectations, but importantly management haven’t over-promised and failed to deliver ( metalsone style)
Pulawy – CRMA strategic status is meaningful. However, it remains capital-dependent. If the SPAC executes as planned, this is where structured funding could convert concept into construction.
Germany (GmbH) – First site to confirm nameplate expansion. Positive signal. What’s less clear is the pace of commissioning and whether expansion works have formally commenced.
GBD – A performance-enhancing process layered onto HPMS. Strategically important if rolled out across sites, but we’ve had limited visibility on adoption plans beyond initial disclosure.
execution visibility is the missing piece. Once operational data becomes consistent and measurable, valuation should become less theoretical and more mechanical